Post procedural swelling

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
0 Commercial trials
Drug classes (ATC)
C Cardiology (ATC C) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Cesra Arzneimittel GmbH & Co. KG Academic
    DRY EXTRACT OF HORSE CHESTNUT, STANDARDISED (DER 5-7:1), ADJUSTED TO 12.5 MG OF TRITERPENE GLYCOSIDES CALCULATED AS PROTOAESCIGENIN, EXTRACTION SOLVENT: ETHANOL 50% (M/M)
    2022-501154-11-00 1 country 2023 n=60
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Cesra Arzneimittel GmbH & Co. KG Academic 1 Phase II 0
New trials by year
2023
1
← All indication landscapes